Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.

Meanwhile, the UK’s FTSE 100 lost 1.1%, pressured by a spike in gilt yields after a report said Finance Minister Rachel ...

Q3 2025 Earnings Call November 14, 2025 9:00 AM ESTCompany ParticipantsGordon Johnston - President, CEO & DirectorVito Culmone ...